Search

Your search keyword '"Anastassiadou, Maria"' showing total 136 results

Search Constraints

Start Over You searched for: Author "Anastassiadou, Maria" Remove constraint Author: "Anastassiadou, Maria" Topic mrl review Remove constraint Topic: mrl review
136 results on '"Anastassiadou, Maria"'

Search Results

1. Review of the existing maximum residue levels for 8‐hydroxyquinoline according to Article 12 of Regulation (EC) No 396/2005.

2. Review of the existing maximum residue levels for pinoxaden according to Article 12 of Regulation (EC) No 396/2005.

3. Review of the existing maximum residue levels for cyproconazole according to Article 12 of Regulation (EC) No 396/2005.

4. Evaluation of confirmatory data following the Article 12 MRL review for propiconazole.

5. Review of the existing maximum residue levels for sulfuryl fluoride according to Article 12 of Regulation (EC) No 396/2005.

6. Review of the existing maximum residue levels for thiram according to Article 12 of Regulation (EC) No 396/2005.

7. Evaluation of confirmatory data following the Article 12 MRL review and setting of import tolerances for bifenthrin in maize grain and sweet corn.

8. Review of the existing maximum residue levels for quinoxyfen according to Article 12 of Regulation (EC) No 396/2005.

9. Evaluation of confirmatory data following the Article 12 MRL review and setting of an import tolerance for flutriafol in cucurbits (inedible peel).

10. Review of the existing maximum residue levels for oxyfluorfen according to Article 12 of Regulation (EC) No 396/2005.

11. Review of the existing maximum residue levels for pyroxsulam according to Article 12 of Regulation (EC) No 396/2005.

12. Review of the existing maximum residue levels for Streptomyces lydicus strain WYEC 108 according to Article 12 of Regulation (EC) No 396/2005.

13. Review of the existing maximum residue levels for chlorantraniliprole according to Article 12 of Regulation (EC) No 396/2005.

14. Review of the existing maximum residue levels for Pseudomonas sp. strain DSMZ 13134 according to Article 12 of Regulation (EC) No 396/2005.

15. Evaluation of confirmatory data following the Article 12 MRL review and modification of the existing maximum residue levels for azoxystrobin.

16. Review of the existing maximum residue levels for aminopyralid according to Article 12 of Regulation (EC) No 396/2005.

17. Review of the existing maximum residue levels for 6‐benzyladenine according to Article 12 of Regulation (EC) No 396/2005.

18. Setting of import tolerances, modification of existing maximum residue levels and evaluation of confirmatory data following the Article 12 MRL review for flupyradifurone and DFA.

19. Evaluation of confirmatory data following the Article 12 MRL review for flonicamid.

20. Review of the existing maximum residue levels for Bacillus pumilus QST 2808 according to Article 12 of Regulation (EC) No 396/2005.

21. Evaluation of confirmatory data following the Article 12 MRL review for aclonifen.

22. Review of the existing maximum residue levels for fluopyram according to Article 12 of Regulation (EC) No 396/2005.

23. Review of the existing maximum residue levels for spirotetramat according to Article 12 of Regulation (EC) No 396/2005.

24. Review of the existing maximum residue levels for ipconazole according to Article 12 of Regulation (EC) No 396/2005.

25. Review of the existing maximum residue levels for tefluthrin according to Article 12 of Regulation (EC) No 396/2005.

26. Review of the existing maximum residue levels for metamitron according to Article 12 of Regulation (EC) No 396/2005.

27. Review of the existing maximum residue levels for bixafen according to Article 12 of Regulation (EC) No 396/2005.

28. Evaluation of confirmatory data following the Article 12 MRL review for 1-methylcyclopropene.

29. Review of the existing maximum residue levels for diclofop (considered variant diclofop-methyl) according to Article 12 of Regulation (EC) No 396/2005.

30. Review of the existing maximum residue levels for thiencarbazone-methyl according to Article 12 of Regulation (EC) No 396/2005.

31. Review of the existing maximum residue levels for benalaxyl-M according to Article 12 of Regulation (EC) No 396/2005.

32. Review of the existing maximum residue levels for pyridaly laccording to Article 12 of Regulation (EC) No 396/2005.

33. Evaluation of confirmatory data following the Article 12 MRL review for fluroxypyr.

34. Review of the existing maximum residue levels for hymexazol according to Article 12 of Regulation (EC) No 396/2005.

35. Review of the existing maximum residue levels for penflufen according to Article 12 of Regulation (EC) No 396/2005.

36. Evaluation of confirmatory data following the Article 12 MRL review for cymoxanil.

37. Review of the existing maximum residue levels for emamectin according to Article 12 of Regulation (EC) No 396/2005.

38. Evaluation of confirmatory data following the Article 12 MRL review for oryzalin.

39. Review of the existing maximum residue levels for fluopicolide according to Article 12 of Regulation (EC) No 396/2005.

40. Review of the existing maximum residue levels for bupirimate according to Article 12 of Regulation (EC) No 396/2005.

41. Evaluation of confirmatory data following the Article 12 MRL review for bentazone.

42. Review of the existing maximum residue levels for clethodim according to Article 12 of Regulation (EC) No 396/2005.

43. Evaluation of confirmatory data following the Article 12 MRL review for dimethenamid‐P.

44. Evaluation of confirmatory data following the Article 12 MRL review for spinosad.

45. Evaluation of confirmatory data following the Article 12 MRL review for imazamox.

46. Review of the existing maximum residue levels for spiromesifen according to Article 12 of Regulation (EC) No 396/2005.

47. Review of the existing maximum residue levels for metam according to Article 12 of Regulation (EC) No 396/2005.

48. Review of the existing maximum residue levels for dazomet according to Article 12 of Regulation (EC) No 396/2005.

49. Review of the existing maximum residue levels for imidacloprid according to Article 12 of Regulation (EC) No 396/2005.

50. Review of the existing maximum residue levels for fluometuron according to Article 12 of Regulation (EC) No 396/2005.

Catalog

Books, media, physical & digital resources